Join us for a conversation about your fertility, genetics, and the proactive steps you can take today to reach your future family building goals. During the discussion, we will talk about the advances in DNA and reproductive health technology, and how this information is empowering women to make smarter decisions about their health and take greater control of their biological clock.
Appetizers, wine, beer, and non-alcoholic beverages will be served. Plus, each attendee will receive a $100 voucher for the Fertilome genetic test. We’ll also answer questions, such as:
- I’m interested in having kids someday but am not sure when, are there any proactive steps I can take now?
- I’m considering freezing my eggs, is it worth the investment?
- I’ve always had painful periods, should I be worried it might be something more serious like endometriosis?
- I have irregular or missed periods, should I be concerned it may be symptom of a reproductive condition like PCOS?
- 6:30-7:00 PM: Networking
- 7:00-8:00 PM: Presentation
- 8:00-8:30 PM: Q&A
- Angie Lee, Chief Product Officer, Celmatix
- Dr. Indrani Chatterjee, Medical Science Liaison, Celmatix
Angie Lee is the Chief Product Officer at Celmatix, where she oversees product, engineering, and brand. She brings over 15 years of consumer product and brand strategy experience. Most recently she was the head of marketing and communications at General Assembly. Previously, Angie advised clients on new product launches at IDEO, and oversaw the launch of more than 100 New York Times bestsellers at HarperCollins Publishers. Angie has an MBA from NYU and is a graduate of the University of Texas’s Business Honors Program. Angie currently lives in Brooklyn, NY with her husband and kids.
Dr. Indrani Chatterjee
Dr. Indrani Chatterjee is currently the Medical Science Liaison at Celmatix, where she serves as the scientific resource for product development. Before Celmatix, Indrani was a postdoc at the Center for Genomics and Systems Biology, NYU, where her research was focused on the global genetic architecture that underlies fertilization and early embryonic development using high-throughput genome wide RNA interference screens.
Hosted by Celmatix
Celmatix is a next-generation women’s health company transforming reproductive healthcare through genomics and big data. Founded in 2009 in New York City, Celmatix is disrupting how women approach their lifelong fertility journey by empowering them with more personalized information. The company’s research-driven products include Fertilome® genetic test, the world’s first multigene panel that reveals what a woman’s DNA says about her reproductive health, and Polaris®, a real-time predictive analytics platform used by leading fertility clinics across the U.S., which helps physicians optimize patient outcomes and improve the patient experience.